Medicine and Dentistry
Absence
16%
Acute Graft Rejection
23%
Adverse Event
8%
Allograft
11%
Antihypertensive Agent
14%
B Cell
32%
Biological Marker
11%
Biopsy
22%
Bleeding
17%
Bleeding Time
10%
Calcineurin Inhibitor
16%
Cell Therapy
16%
Circulating Endothelial Cell
14%
Cyclosporine
18%
Delayed Graft Function
17%
Drug Megadose
14%
Endothelial Cell
14%
Esophagus Ulcer
14%
Graft Rejection
14%
Graft Survival
17%
Heart Death
14%
Immigrant
14%
Immunoglobulin
14%
Immunosuppressive Drug
11%
Immunosuppressive Treatment
10%
Infection
8%
Insulin Treatment
12%
Intensive Care Unit
14%
Kidney Allograft
34%
Kidney Graft
82%
Kidney Transplantation
100%
Liver Graft
14%
Machine Perfusion
29%
Maturity Onset Diabetes of the Young
7%
Meta-Analysis
29%
Monoclonal Antibody
14%
Mycophenolic Acid
7%
Open-Label Trial
14%
Patient with Type 2 Diabetes
14%
Prednisone
9%
Renal Biopsy
14%
Rituximab
37%
Systematic Review
29%
T Cell
13%
T Lymphocyte
14%
Tacrolimus
16%
Telemedicine
14%
Thrombocyte Function
14%
Transplantation
53%
Ulcer
9%
Immunology and Microbiology
Acute Graft Rejection
42%
Alemtuzumab
14%
Allograft
14%
Allotransplantation
31%
Anti-Thymocyte Globulin
14%
Antibody Mediated Rejection
12%
B Cell
65%
CD4
6%
Chimera
14%
Cytokine
15%
Cytokine Production
14%
Cytokine Release
14%
Drug Megadose
14%
Immune Response
10%
Immunocompetent Cell
9%
Immunosuppression
11%
Immunosuppressive Drug
14%
Innate Immune System
9%
Interleukin 17
15%
Interleukin 6
6%
Intravenous Immunoglobulin
14%
Kidney Allograft Rejection
13%
Kidney Transplantation
99%
Macrophage Inflammatory Protein 1
8%
Monoclonal Antibody
17%
Monocyte
7%
Mycophenolic Acid
8%
Prednisone
14%
Rituximab
92%
T Cell
51%
T Lymphocyte Antibody
20%
Tacrolimus
10%
Transplant Procedure
93%
Transplant Rejection
14%
Vein
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Graft Rejection
28%
Adverse Event
10%
Alemtuzumab
29%
Antihypertensive Agent
14%
Antiviral Therapy
7%
Calcineurin Inhibitor
16%
Chloroquine
7%
Ciclosporin
18%
Cytokine
14%
Delayed Graft Function
14%
Disease Course
7%
Drug Concentration
14%
End Stage Liver Disease
7%
Esophagus Ulcer
14%
Frailty
14%
Graft Failure
14%
Graft Rejection
7%
Heart Death
14%
Immunoglobulin
14%
Immunosuppressive Agent
20%
Infection
6%
Kidney Allograft Rejection
20%
Kidney Graft Rejection
7%
Leporidae
10%
Macrophage Inflammatory Protein 1
8%
Membranous Glomerulonephritis
14%
Monoclonal Antibody
17%
Non Insulin Dependent Diabetes Mellitus
14%
Prednisone
9%
Random Effects Model
7%
Remission
5%
Rituximab
52%
Side Effect
11%
Symptom
7%
T Lymphocyte Antibody
20%
Tacrolimus
13%
Thymocyte Antibody
29%
Ulcer
9%